Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Recruiting

Phase 2

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsDosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT03587844

Conditions

Mycosis Fungoides

Lymphomatoid Papulosis

Sezary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

brentuximab vedotin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information